蝨子治疗市场－全球产业规模、份额、趋势、机会和预测，按类型、药物、配销通路、地区和竞争格局划分，2021-2031年预测

全球蝨子治疗市场规模将从2025年的11.4亿美元成长到2031年的15.7亿美元，年复合成长率为5.48%。该市场涵盖外用杀蝨剂（如洗髮精和乳液）以及用于根除头蝨感染的机械去除设备。市场成长的主要驱动因素是学龄儿童头蝨感染的持续流行以及非处方治疗药物的日益普及。

主要市场驱动因素

学龄儿童头蝨感染率的不断攀升是蝨子治疗市场持续成长的主要推动因素。这种疾病在教育和托幼机构中透过直接的头部接触迅速传播，从而导致对有效根除方案的周期性需求。

主要市场挑战

头蝨对拟除虫菊酯类製剂的生物抗药性日益增强，这构成了全球蝨子治疗市场成长的巨大障碍。这种生理适应性在一些被称为「超级蝨子」的蝨株中表现得尤为明显，使得许多标准的非处方杀蝨剂失效。

主要市场趋势

由于蝨子对传统拟除虫菊酯类药物的抗药性日益严重，市场正经历着向无毒且作用机制为物理作用的製剂的重大转变。消费者和医疗保健提供者越来越倾向于使用含有多杀菌素或二甲硅油等成分的产品，这些成分利用机械或新型生物机制来根除蝨子，而不是依赖神经毒性化学物质。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球蝨子治疗市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依类型（头蝨病、体蝨病、阴蝨病）
  • 依药品分类（非处方药、处方药）
  • 按配销通路（医院药房、零售药房、网路药房）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美蝨子治疗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲蝨子治疗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区蝨子治疗市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东与非洲蝨子治疗市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲蝨子治疗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球蝨子治疗市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Alliance Pharmaceuticals
• Omega Pharma
• Prestige Brands Holdings Inc.
• Johnson & Johnson
• Fleming Medical Ltd
• Oystershell Consumer Health, Inc
• Nisarg Pharma
• ParaPRO Pharmaceuticals
• ICB Pharma
• Marico

第十六章：策略建议

第17章调查会社について・免责事项

The Global Lice Treatment Market will grow from USD 1.14 Billion in 2025 to USD 1.57 Billion by 2031 at a 5.48% CAGR. The Global Lice Treatment Market encompasses topical pediculicides, such as shampoos and lotions, alongside mechanical removal devices designed for the eradication of pediculosis infestations. The market's trajectory is fundamentally supported by the persistent prevalence of head lice among school-aged children and the expanding accessibility of over-the-counter therapeutic options.

Key Market Drivers

The escalating prevalence of pediculosis capitis among school-aged children serves as a primary catalyst for the sustained growth of the lice treatment market. This condition spreads rapidly in educational and childcare settings through direct head-to-head contact, creating a cyclical demand for effective eradication solutions. As classrooms and extracurricular activities facilitate transmission, the sheer volume of infestations necessitates frequent therapeutic interventions by parents and guardians.

Key Market Challenges

The escalating biological resistance of head lice to pyrethroid-based formulations constitutes a formidable barrier to the growth of the Global Lice Treatment Market. This physiological adaptation, observed in strains widely known as "super lice," renders many standard over-the-counter pediculicides ineffective. When these established chemical treatments fail to eradicate infestations, consumer confidence in conventional product lines diminishes significantly.

Key Market Trends

The market is witnessing a decisive transition toward non-toxic and physical mode-of-action formulations as a response to the widespread resistance of lice to traditional pyrethroid-based treatments. Consumers and healthcare providers are increasingly favoring products containing ingredients like spinosad or dimethicone, which utilize mechanical or novel biological mechanisms to eradicate infestations rather than relying on neurotoxic chemicals. This shift is driving significant revenue growth for pharmaceutical companies holding rights to these advanced therapies.

Key Market Players

• Alliance Pharmaceuticals
• Omega Pharma
• Prestige Brands Holdings Inc.
• Johnson & Johnson
• Fleming Medical Ltd
• Oystershell Consumer Health, Inc
• Nisarg Pharma
• ParaPRO Pharmaceuticals
• ICB Pharma
• Marico

Report Scope:

In this report, the Global Lice Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lice Treatment Market, By Type:

• Pediculosis Capitis
• Pediculosis Corporis
• Pediculosis Pubis

Lice Treatment Market, By Drugs:

• OTC Drugs
• Prescription Drugs

Lice Treatment Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Lice Treatment Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lice Treatment Market.

Available Customizations:

Global Lice Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lice Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis)
  • 5.2.2. By Drugs (OTC Drugs, Prescription Drugs)
  • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Lice Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Drugs
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Lice Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Drugs
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Lice Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Drugs
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Lice Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Drugs
      • 6.3.3.2.3. By Distribution Channel

7. Europe Lice Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Drugs
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Lice Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Drugs
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Lice Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Drugs
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Lice Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Drugs
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Lice Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Drugs
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Lice Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Drugs
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Lice Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Drugs
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Lice Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Drugs
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Lice Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Drugs
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Lice Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Drugs
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Lice Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Drugs
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Lice Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Drugs
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Lice Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Drugs
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Lice Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Drugs
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Lice Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Drugs
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Lice Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Drugs
      • 9.3.3.2.3. By Distribution Channel

10. South America Lice Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Drugs
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Lice Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Drugs
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Lice Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Drugs
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Lice Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Drugs
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Lice Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Alliance Pharmaceuticals
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Omega Pharma
• 15.3. Prestige Brands Holdings Inc.
• 15.4. Johnson & Johnson
• 15.5. Fleming Medical Ltd
• 15.6. Oystershell Consumer Health, Inc
• 15.7. Nisarg Pharma
• 15.8. ParaPRO Pharmaceuticals
• 15.9. ICB Pharma
• 15.10. Marico

16. Strategic Recommendations

17. About Us & Disclaimer